Score Overview
See the full market ranking โ
Akari Therapeutics PLC fundamental performance
Across Akari Therapeutics PLC's full reported history, from 2015 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 45M to -$ 17M. Revenue increased in 0% of the years measured; net income in 45%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.18 | โ |
1 Year2025-08-12 | $ 40.80 | -82.40% |
5 Years2021-08-12 | $ 1.37K | -99.48% |
10 Years2016-08-12 | $ 7.36K | -99.90% |
All Time2015-09-21 | $ 25.2K | -99.97% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-09-21 |
|---|---|---|---|---|---|
| Price | $ 7.18 | $ 40.80 | $ 1.37K | $ 7.36K | $ 25.2K |
| Return | โ | -82.40% | -99.48% | -99.90% | -99.97% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 28M | $ 2M |
| 2025 | $ 0.00 | -$ 17M | $ 5M |
| 2024 | $ 0.00 | -$ 19M | $ 2M |
| 2023 | $ 0.00 | -$ 10M | $ 3M |
| 2022 | $ 0.00 | -$ 17M | $ 13M |
| 2021 | $ 0.00 | -$ 17M | $ 9M |
| 2020 | $ 0.00 | -$ 17M | $ 14M |
| 2019 | $ 0.00 | -$ 16M | $ 5M |
| 2018 | $ 0.00 | -$ 19M | $ 5M |
| 2017 | $ 0.00 | -$ 27M | $ 28M |
| 2016 | $ 0.00 | -$ 18M | $ 44M |
| IPO2015 | $ 0.00 | -$ 45M | $ 68M |
Explore beyond AKTX
You're looking at Akari Therapeutics PLC. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
